Why Chemed Corporation’s (CHE) Stock Is Up 9.40%
As of Wednesday, October 28, Chemed Corporation’s CHE share price has surged by 9.40%, which has investors questioning if this is right time to sell.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Commentary & Analysis
What You Need to Know About Chemed Corporation's Q4 Earnings
Chemed Corporation's fiscal Q4 earnings report was released on Tuesday, October 27. Let's dive in to see if (CHE) missed or beat analyst's expectations.Rosalio Madrigal
Which Is a Better Investment, Chemed Corporation or NeoGenomics, Inc. Stock?
Learn more about whether Chemed Corporation or NeoGenomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Why Chemed Corporation’s (CHE) Stock Is Up 5.25%
As of Wednesday, July 29, Chemed Corporation’s CHE share price has surged by 5.25%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
What You Need to Know About Chemed Corporation's Q3 Earnings
Chemed Corporation's fiscal Q3 earnings report was released on Tuesday, July 28. Let's dive in to see if (CHE) missed or beat analyst's expectations.Rosalio Madrigal
Financial Summary
| Share Statistics | CHE | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $7,110.4 | $2,049.0 | 73% |
|
| Shares Out (Mil) | 13.1 | 79.7 | 24% |
|
| Institutional Ownership | 98.5% | 85.9% | 79% |
|
| Float (Mil) | 11.8 | 58.3 | 22% |
|
| Beta | 0.51 | 0.78 | 29% |
|
| Avg Daily Volume (000s) | 189 | 661 | 45% |
|
| Price Change (52-week) |
24.5% | 83.6% | 71% |
|
| Growth | CHE | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 4.0% | 10.4% | 32% |
|
| Net Income (5yr) | (3.7%) | (1.1%) | 35% |
|
| EPS (5yr) | (1.2%) | 1.2% | 29 |
|
| Dividends (5yr) | 10.8% | 0.0% | 92% |
|
| Cash Flow (5yr) | (22.3%) | (17.3%) | 29% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 5 | 5 | 5 | |
| Current EPS | $7.352 | $25.775 | $27.850 | |
| Month Ago EPS | $7.375 | $25.494 | $27.518 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | $7.345 | $25.523 | $27.525 | |
| Year/Year Chg | 34.9% | 40.5% | 66.8% | |
| Financials | CHE | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,661 | $1,532 | 64% |
|
| Net Income (TTM) (Mil) | $282 | $31 | 71% |
|
| EPS (TTM) | $20.963 | $0.300 | 98% |
|
| Operating Cash Flow (TTM) (Mil) | $363 | $168 | 67% |
|
| Net Cash Flow (TTM) (Mil) | ($81) | $2 | 16% |
|
| Long-Term Debt (Q1) (Mil) | $351 | $394 | 55% |
|
| Enterprise Value (Q1) (Mil) | $7,303 | $2,409 | 69% |
|
| Valuation | CHE | Industry Median |
Percentile (All Stocks) |
|
| P/B | 8.25 | 2.97 | 89% |
|
| P/E | 26.2 | 28.0 | 65% |
|
| Dividend Yield | 0.5% | 0.0% | 62% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | CHE | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 33.5% | 27.0% | 40% |
|
| Net Margin | 10.6% | 1.3% | 63% |
|
| ROA | 16.9% | 2.2% | 94% |
|
| ROE | 29.1% | 6.8% | 87% |
|
| Liabilities to Assets | 49.9% | 61.5% | 42% |
|
| F-Score | 7 | 5 | 82% |
|
Chemed Corporation did not pass any screens on 11/4/2026.
